跳至主要内容
临床试验/NCT03026413
NCT03026413已完成不适用

The Comparison Between the Pulmonary Vein Antrum Modification by SmartTouch Ablation Catheter With Contact Force Monitoring and Circumferential Pulmonary Vein Isolation by That Without Contact Force Monitoring Plus Lasso Catheter for the Patients of Paroxysmal Atrial Fibrillation: a Randomized Controlled Trial

The First Affiliated Hospital with Nanjing Medical University0 个研究点目标入组 180 人开始时间: 2015年3月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
180
主要终点
any recorded atrial arrhythmias proved by 7-day holter

研究概览

简要总结

To compare the efficacy and safety of circumferential pulmonary vein isolation without contact force with the pulmonary vein antrum modification for patients of paroxysmal atrial fibrillation.

详细描述

This is a single centre, prospective control study. The study will enroll 180 patients with 2:1 grouped.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with paroxysmal atrial fibrillation refractory to drugs
  • with consent

排除标准

  • LVEF<50%
  • history of cardiac surgery
  • valvular heart disease
  • abnormal thyroid function
  • left atrial thrombus

研究组 & 干预措施

PVAM

Experimental

pulomonary vein antrum modification with contact force monitoring for AF

干预措施: pulmonary vein antrum modification (Procedure)

Control arm

Active Comparator

pulmonary vein isolation without contact force

干预措施: pulmonary vein antrum modification (Procedure)

结局指标

主要结局

any recorded atrial arrhythmias proved by 7-day holter

时间窗: at least 18 months follow up

sustained at least 30s

次要结局

  • procedure time(time during patient enrollment)
  • x ray time(time during patient enrollment)
  • adverse event(at least 18 months follow up)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Minglong Chen

Professor and Director of Cardiac EP Vice Director of Dept. of Cardiology

The First Affiliated Hospital with Nanjing Medical University

相似试验

Unknown
4 期
Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drug Treatment in Subjects With Recurrent Atrial FibrillationAtrial Fibrillation
NCT02475642VZW Cardiovascular Research Center Aalst152
进行中(未招募)
1 期
Continuing versus stopping heart rhythm medication after an operation restoring your normal heart rhythm in patients with a heart rhythm disorder: a study across multiple hospitals.Symptomatic persistent atrial fibrillation: atrial fibrillation, that lasts longer than 7 days, including episodes that are terminated by cardioversion, either with drugs or by direct current cardioversion, after 7 days or more. Episodes of atrial fibrillation have to be accompanied by symptoms.MedDRA version: 20.0Level: LLTClassification code 10071667Term: Persistent atrial fibrillationSystem Organ Class: 100000004849
EUCTR2018-002103-33-DKAZ Sint-Jan Brugge-Oostende AV220
进行中(未招募)
1 期
Continuing versus stopping heart rhythm medication after an operation restoring your normal heart rhythm in patients with a heart rhythm disorder: a study across multiple hospitals.Symptomatic persistent atrial fibrillation: atrial fibrillation, that lasts longer than 7 days, including episodes that are terminated by cardioversion, either with drugs or by direct current cardioversion, after 7 days or more. Episodes of atrial fibrillation have to be accompanied by symptoms.MedDRA version: 20.0 Level: LLT Classification code 10071667 Term: Persistent atrial fibrillation System Organ Class: 100000004849
EUCTR2018-002103-33-ESAZ Sint-Jan Brugge-Oostende AV220
进行中(未招募)
1 期
Continuing versus stopping heart rhythm medication after an operation restoring your normal heart rhythm in patients with a heart rhythm disorder: a study across multiple hospitals.Symptomatic persistent atrial fibrillation: atrial fibrillation, that lasts longer than 7 days, including episodes that are terminated by cardioversion, either with drugs or by direct current cardioversion, after 7 days or more. Episodes of atrial fibrillation have to be accompanied by symptoms.MedDRA version: 20.0 Level: LLT Classification code 10071667 Term: Persistent atrial fibrillation System Organ Class: 100000004849
EUCTR2018-002103-33-FRAZ Sint-Jan Brugge-Oostende AV220
进行中(未招募)
1 期
Continuing versus stopping heart rhythm medication after an operation restoring your normal heart rhythm in patients with a heart rhythm disorder: a study across multiple hospitals.Symptomatic persistent atrial fibrillation: atrial fibrillation, that lasts longer than 7 days, including episodes that are terminated by cardioversion, either with drugs or by direct current cardioversion, after 7 days or more. Episodes of atrial fibrillation have to be accompanied by symptoms.MedDRA version: 20.0 Level: LLT Classification code 10071667 Term: Persistent atrial fibrillation System Organ Class: 100000004849
EUCTR2018-002103-33-ATAZ Sint-Jan Brugge-Oostende AV220